Skip to main content
. 2016 Dec 7;113(51):14745–14750. doi: 10.1073/pnas.1618582114

Fig. S6.

Fig. S6.

Effects of MIA-602 in PAK1-silenced GC cells. (A) KATO-III (Left) and SGC-7901 (Right) cells were transiently transfected with PAK1 siRNAs or scramble (Scr) siRNA for 48 h and then were subjected to Western blotting for the indicated antigens. β-Actin was used as an internal control. (B) Cell viabilities of PAK1-silenced cells that were treated with MIA-602 (1 μM) or vehicle for 48 h were assessed by MTT assays. Error bars indicate SEM. *P < 0.05, **P < 0.01 by a one-way ANOVA with post hoc intergroup comparisons; n = 3 in each group.